摘要
目的:采用meta分析法分析用三黄泻心汤治疗动脉粥样硬化(AS)的效果。方法:在PubMed、EMBASE、CENTRAL、CBM及CNKI等数据库中检索用三黄泻心汤治疗动脉粥样硬化的相关文献。对文献进行筛选及数据提取。对提取的数据进行meta分析。然后,观察分析的结果。结果:进行检索及筛选后,最终选择3篇符合规定的文献纳入本次研究。对3篇文献中的数据进行meta分析的结果显示,治疗后,两组患者血清C反应蛋白(CRP)的含量相比,差异不具有统计学意义(P>0.05);三黄泻心汤组患者血清肿瘤坏死因子-α(TNF-α)的含量、血清白细胞介素-6(IL-6)的含量、血清总胆固醇(TC)的含量、血清低密度脂蛋白胆固醇(LDL-C)的含量、血清内皮素(ET)的含量、血浆血栓烷素B_(2)(TXB_(2))的含量及脑血管事件的发生率均低于常规治疗组患者,其血清高密度脂蛋白胆固醇(HDL-C)的含量及血清6-酮-前列腺素F1α(6-keto-PGF1α)的含量均高于常规治疗组患者,差异具有统计学意义(P<0.05)。结论:用三黄泻心汤治疗AS的效果显著,可降低患者血清炎症因子的含量,改善其血脂指标及血管内皮功能。
Objective:To analyze the effect of Sanhuang Xiexin Decoction in the treatment of atherosclerosis(AS)by Meta analysis.METHODS:The literatures about Sanhuang Xiexin Decoction in the treatment of atherosclerosis were retrieved from PubMed,EMBASE,Central,CBM and CNKI databases.Literature screening and data extraction were carried out.Meta-analysis was performed on the extracted data.Then,observe the results of the analysis.RESULTS:After searching and screening,3 articles that meet the requirements were finally selected to be included in this study.Meta-analysis of the data in the three literatures showed that after treatment,there was no significant difference in serum C-reactive protein(CRP)content between the two groups(P>0.05).The contents of tumor necrosis factor-α(TNF-α),interleukin-6(IL-6),total cholesterol(TC),low density lipoprotein cholesterol(LDL-C),serum endothelin(ET),plasma thromboxane B_(2)(TXB_(2))and cerebrovascular events in Sanhuang Xiexin Decoction group were investigated Were lower than those in conventional treatment group,and the content of serum high density lipoprotein cholesterol(HDL-C)and serum 6-keto-prostaglandin F1α(6-Keto-PGF1α)were higher than those in conventional treatment group,with statistical significance(P<0.05).Conclusion:Sanhuang Xiexin Decoction has a significant effect in the treatment of AS,which can reduce the content of inflammatory factors in serum,improve the indexes of blood lipid and vascular endothelial function.
作者
江国华
江沛清
廖思乡
潘梓青
任涵月
杨巧红
JIANG Guohua;JIANG Peiqing;LIAO Sixiang;PAN Ziqing;REN Hanyue;YANG Qiaohong(Shenzhen Clinical School of Medicine,Guangzhou University of Chinese Medicine,Shenzhen 518033;The First Clinical College of Guangzhou University of Chinese Medicine,Guangzhou 510006;School of Basic Medicine,Guangzhou University of Traditional Chinese Medicine,Guangzhou 510006)
基金
国家级大学生创新创业训练计划项目(202010572022)。
关键词
三黄泻心汤
AS
心血管疾病
META分析
Sanhuang Xiexin Decoction
The AS
Cardiovascular disease
Meta analysis